WeightWatchers completes financial reorganization, relists on Nasdaq; appoints new CMO and board members

WW INTERNATIONAL, INC.

Completed financial reorganization with enhanced flexibility; relisted on Nasdaq under ticker WW on July 8, 2025.
Appointed Dr. Kim Boyd as Chief Medical Officer; she previously led at One Medical, Calibrate, and Nurx.
New board includes Mike Mason (former Eli Lilly president of Diabetes & Obesity), Fallon O’Connor-Brooks, and others.
Will launch a perimenopause/menopause program later in 2025 combining medical, nutritional, and community support.
Appointed Uta Knablein as Chief Product Officer; promoted Jacquie Cooke to CLO and Jon Volkmann to COO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.